RELATIVE COMPARISON OF STABILITY AND DEGRADATION OF METHYLCOBALAMIN TABLETS OF DIFFERENT BRANDS AT DIFFERENT STORAGE SETTINGS
Objective: To assess relative comparison of stability and degradation of Methylcobalamin tablets of different brands at various storage circumstances.
Methods: The comparative in vitro study of Methycobal (innovator brand) with its other 5 different brands Cobalamin, Neuromet, Incobal, Qbal and Mecobal was organized for evaluation of physicochemical features of hardness, thickness, friability, weight variation, disintegration time and accelerated stability at 3 temperatures, 25 °C, 30 °C±65 % and 40 °C±75 % respectively for 3 mo. Later all brands were passed through HPLC for checking the extent of degradation of drug products.
Results: All tablet brands were within the weight variation specified limits except Mecobal with a relative standard deviation of 6.83%. The weight variation values of Methycobal, Cobalamin, Neuromet, Incobal, Qbal and Mecobal were 0.29%, 0.11%, 0.09%, 0.13%, 0.09% and 0.14% after friability test respectively as per standard limits. The average thickness of Cobalamin, Incobal and Mecobal were not within specified limits. The average hardness of all trades was within limits except Cobalamin and Mecobal exceeding 6kp. The disintegration time of all companies was as per specifications.
Conclusion: Qbal was found economical and cost-effective. However, study facts unveiled no noteworthy variety in the Q. C assessments of Methylcobalamin brands.
2. Zhang M, Han W, Hu S, Xu H. Methylcobalamin; a potential vitamin of pain killer. Neural Plast 2013;6:651-424.
3. Colledge NR, Walker BR, Ralston SH. Davidson’s principles and practice of medicine. 21st edition. London Churchill Livingstone; 2010. p. 1020-2.
4. Sambulingam K, Sambulingam P. Essentials of medical physiology. New Delhi Jaypee Brothers Medical Publishers. 5th edition; 2010. p. 73.
5. Hunt A, Harrington D, Robinson S. Vitamin B12 deficiency. Br Med J 2014;349:g52-26.
6. Stabler SP. Vitamin B12 deficiency. N Engl J Med 2013;368:160-49.
7. Langan RC, Zawistoski KJ. Update on vitamin B12 deficiency. Am Fam Physician 2011;83:1430-25.
8. Molloy AM, Kirke PN, Troendle JF, Burke H, Sutton M, Brody LC, et al. Maternal vitamin B12 status and risk of neural tube defects in a population with high neural tube defect prevalence and no folic acid fortification. Pediatrics 2009;123:923-17.
9. Monto RW, Rebuck JW, Brennan MJ. Inhalation and nasal instillation of crystalline b12 therapy in pernicious anemia. Henry Ford Hosp Med J 1953;1:20-15.
10. Mohamad SA, Abdelkader H, Elrehany M, Mansour HF. Vitamin B12 buccoadhesive tablets, auspicious non-invasive substitute for intramuscular injection formulation, in vitro and in vivo appraisal. Drug Dev Ind Pharm 2019;45:244-51.
11. Chamle AH, Shane NLJ, Pai A, Muddukrishna BS. Photodegradation of methylcobalamin and its determination in a commercial formulation. Indian J Pharm Sci 2019;81:62-57.
12. Rahman ZU, Khan I, Baig A, Quraishi AR, Zahir. Post-market in vitro comparative evaluation of quality control parameters of paracetamol compressed tablets manufactured in local industrial zones of kpk Pakistan. Pharma Innovation J 2013;2:15-1.
13. Karmakar P, Kibria MG. In vitro comparative evaluation of quality control parameters between paracetamol and paracetamol/caffeine tablets available in Bangladesh. Int J Curr Pharm Res 2012;1:109-3.
14. Chandrasekaran AR, Han CY, Yang AC, Cheang LW, Ping LS. Post–market in vitro equivalency evaluation of paracetamol tablets in Kedah, Malaysia. IJPSN 2011;4:1407-3.
15. HT Guideline. Stability testing of new drug substances and products. QIA (R2), Curr Step 2013;4:24-1.
16. Bajaj S, Singla D, Sakhuja N. Stability testing of pharmaceutical products. J Appl Pharm Sci 2012;2:129-38.
17. Mahor A, Alok S, Gupta Y, Jain S. Body distribution and stability studies on mitoxantrone loaded solid lipid nanoparticles conjugated with concanavalin a. Int J Pharm Pharm Sci 2010;2:42-39.
18. Zothanpuii F, Rajesh R, Selvakumar K. A review 0n stability testing guidelines of pharmaceutical products. Asian J Pharm Clin Res 2020;13:9-3.
This work is licensed under a Creative Commons Attribution 4.0 International License.